Today: 31 May 2026
ABM Industries (ABM) Stock Slides After Earnings: Record 2025 Revenue, WGNSTAR Acquisition, Dividend Hike and 2026 Forecasts (Dec. 19, 2025)
19 December 2025
4 mins read

ABM Industries (ABM) Stock Slides After Earnings: Record 2025 Revenue, WGNSTAR Acquisition, Dividend Hike and 2026 Forecasts (Dec. 19, 2025)

ABM Industries Incorporated (NYSE: ABM) is ending the week with investors debating a classic market paradox: record revenue and a bigger dividend on one side, and a sharp earnings miss plus fresh analyst caution on the other. On Friday, December 19, ABM shares traded around $41.78, down about 3.9% on the day, as the market continued to digest the company’s fiscal fourth-quarter report, its $275 million WGNSTAR acquisition agreement, and new Wall Street commentary.

What happened to ABM stock this week?

ABM’s volatility has been tied to a rapid sequence of headline catalysts:

  • Dec. 17: ABM reported fiscal Q4 and full-year FY2025 results and issued FY2026 outlook.
  • Dec. 17: ABM also announced a definitive agreement to acquire WGNSTAR (semiconductor and high-tech services).
  • Dec. 18: Analysts turned more cautious on margin trajectory and leverage, including a UBS downgrade.
  • Dec. 19: ABM stock remained under pressure as investors reassessed near-term profitability versus the longer-term growth narrative in technical and semiconductor-related services.

The initial reaction wasn’t uniformly negative. Reuters reported ABM shares rose about 2.5% in premarket trading after the earnings release, noting revenue topped estimates even as EPS fell short.

The core earnings story: revenue record, EPS miss

ABM’s fiscal fourth quarter delivered a new quarterly revenue record of $2.3 billion, up 5.4% year over year (including 4.8% organic growth).

But the bottom line was the flashpoint. ABM posted adjusted EPS of $0.88, below analyst expectations of about $1.09 cited by multiple market trackers.

Management pointed to prior-year self-insurance adjustments as a major drag on comparability: the quarter included a $15.8 million negative impact from prior-year self-insurance adjustments (recognized in the current period) and $9.5 million of restructuring costs, among other items.

Segment performance: why “Technical Solutions” mattered most

One reason ABM’s revenue growth has been getting attention is where it’s coming from.

In Q4, ABM said revenue growth was led by:

  • Technical Solutions (ATS): +16%
  • Manufacturing & Distribution: +8%
  • Aviation: +7%

Reuters highlighted that the Technical Solutions jump was tied to higher microgrid project activity, a niche but fast-growing corner of facility infrastructure as customers prioritize energy resilience.

Dividend news: ABM extends a rare streak

ABM’s board approved a 9% increase in the quarterly cash dividend to $0.29 per share (from $0.265). The dividend is payable Feb. 2, 2026, to shareholders of record Jan. 14, 2026.

That hike also marked ABM’s 58th consecutive year of annual dividend increases, which is why the company is frequently grouped among the market’s long-running dividend growers.

Buybacks and balance sheet: confidence signal, but leverage is a theme

ABM also leaned on shareholder returns via repurchases. The company said it repurchased:

  • $73.0 million of shares in Q4
  • $121.3 million for the full fiscal year
  • leaving $183 million remaining under its repurchase program

On leverage and liquidity, ABM reported quarter-end total indebtedness of $1.6075 billion, a total leverage ratio of 2.7x (as defined by its credit facility), and available liquidity of $681.6 million, including $104.1 million in cash and equivalents.

This matters because the WGNSTAR deal changes the balance-sheet conversation (more on that next), and analysts have been explicitly linking ABM’s near-term upside to the company’s ability to protect margins and keep financial flexibility.

WGNSTAR acquisition: ABM’s big bet on semiconductor onshoring

On Dec. 17, ABM announced a definitive agreement to acquire WGNSTAR in a cash transaction valued at approximately $275 million.

WGNSTAR is positioned in semiconductor and high-tech manufacturing support:

  • Operations across the U.S. and Ireland
  • A workforce of more than 1,300 employees
  • Client relationships “many exceeding two decades,” per ABM GlobeNewswire

ABM said WGNSTAR is expected to generate about $135 million of revenue in calendar 2025, with an expected growth rate of roughly 10%.

The near-term earnings impact is where the market tends to get prickly:

  • The deal is expected to be modestly dilutive to adjusted EPS in fiscal 2026 (largely from amortization of intangibles and interest expense)
  • but $0.05 to $0.07 accretive in fiscal 2027, accelerating thereafter as growth and synergies build

Strategically, ABM framed WGNSTAR as a way to scale its semiconductor platform to roughly $325 million in annualized revenue and to capitalize on U.S. semiconductor onshoring initiatives supported by CHIPS Act incentives and private investment.

ABM’s 2026 forecast: what management is guiding to

For fiscal 2026, ABM guided to:

  • Adjusted EPS of $3.85 to $4.15 (excluding potential positive/negative prior-year self-insurance adjustments)
  • Organic revenue growth of 3% to 4%

ABM also said the WGNSTAR deal is expected to add about one additional point of growth, bringing total expected 2026 revenue growth to ~4% to 5%.

On profitability and below-the-line items, ABM projected:

  • Segment operating margin of 7.8% to 8.0%
  • Interest expense of $95 million to $105 million
  • A “normalized” tax rate of 29% to 30% (excluding discrete/non-taxable items) GlobeNewswire

Analyst updates: UBS downgrade, Baird trims target

Analyst reaction has been a key driver of post-earnings sentiment.

UBS downgraded ABM from Buy to Neutral and cut its price target to $51 from $55, citing concerns including a “flattish” margin trajectory, reduced incremental capital deployment flexibility, and the potential for net leverage to move above 3.0x with the acquisition. Investing.com

Meanwhile, Baird lowered its price target to $52 from $54 while maintaining an Outperform rating, pointing to model updates after results and signs that pricing headwinds may be easing.

For a broader snapshot, some consensus-tracking services place ABM’s average 12‑month price target in the mid‑$50s (with targets spanning the low $50s to upper $50s).

What investors will be watching next

ABM’s story into early 2026 likely comes down to a few practical checkpoints:

  1. Can ABM hold margins steady while growing?
    The company’s own outlook implies a relatively steady margin profile, and UBS is explicitly skeptical that the set-up is ideal without clearer margin expansion.
  2. WGNSTAR integration milestones and leverage path
    ABM expects the transaction to close in fiscal Q2 2026 (subject to regulatory review and customary conditions) and sees FY2026 dilution before FY2027 accretion.
  3. Aviation and Technical Solutions execution
    ABM highlighted major Aviation momentum (including one of its largest aviation awards, expected to generate significant annual revenue when it comes online in calendar 2026) and continued strength in Technical Solutions driven by microgrid activity.
  4. Cash returns versus reinvestment
    ABM increased its dividend and continued buybacks, but future pace will be judged against acquisition financing and balance-sheet flexibility.

Bottom line for ABM stock on Dec. 19, 2025

ABM’s latest headlines paint a company leaning into higher-value facility and technical work—microgrids, semiconductor services, and aviation scale—while navigating the less glamorous realities of contract mix, insurance adjustments, and margin math.

The market’s reaction reflects that tension: revenue momentum and capital returns are supportive, but earnings sensitivity and leverage optics can dominate the conversation in the short run. With ABM trading around the low $40s on Dec. 19, the next leg will likely depend on whether execution in 2026 validates management’s “steady growth” guidance and whether the WGNSTAR deal starts to look like an earnings engine instead of a balance-sheet question mark. GlobeNewswire+2GlobeNewswire+2

Stock Market Today

  • Nanobiotix Raises €85 Million to Advance JNJ-1900 Cancer Treatment Amid Volatile Stock Rally
    May 30, 2026, 6:54 PM EDT. Nanobiotix (ENXTPA:NANO) completed a €85 million global equity raise to fund the development of JNJ-1900 (NBTXR3), a leading cancer treatment candidate. The financing follows promising Phase 2 trial results in inoperable non-small cell lung cancer, sponsored by Johnson & Johnson. Despite a recent 6.6% dip, shares have soared over 79% year-to-date, closing at €34.04, reflecting high market sensitivity to company developments. The fundraise attracted both European and U.S. investors through ordinary shares, American Depositary Shares, and pre-funded warrants issued near the current share price, suggesting robust demand without steep discounting. Investors will closely monitor Nanobiotix's clinical progress, regulatory updates, and potential partnerships, amid dilution concerns due to the new equity issue.

Latest articles

Realty Income Stock Dips Ahead of Jobs Data; Dividend Investors Eye Rates

Realty Income Stock Dips Ahead of Jobs Data; Dividend Investors Eye Rates

31 May 2026
Realty Income closed Friday at $61.28, down from $62.02 the previous week, as property stocks lagged broader market gains. The company declared a $0.2705 monthly dividend, payable June 15 to shareholders of record May 29. CEO Sumit Roy will present at Nareit’s REITweek on June 3. Investors await the U.S. May jobs report on June 5.
Oklo Stock Higher After Plutonium-Fuel Update

Oklo Stock Higher After Plutonium-Fuel Update

31 May 2026
Oklo shares closed at $66.88 Friday, down 1.78%, after a week of gains sparked by news the U.S. Department of Energy selected the company for advanced talks on using surplus plutonium as reactor fuel. Trading volume reached 27.67 million shares. Oklo reported a first-quarter net loss of $33.1 million and ended March with $2.54 billion in cash and equivalents.
Cameco Stock Is Back in Focus After a Mine Restart — What Investors Watch Next

Cameco Stock Is Back in Focus After a Mine Restart — What Investors Watch Next

31 May 2026
Cameco shares closed Friday at C$154.91 on the TSX, up 7.1% for the week after full production resumed at McArthur River and Key Lake following flood-related disruptions. The company kept its 2026 uranium output guidance unchanged at 19.5–21.5 million pounds. CIBC and National Bank of Canada maintained “Outperform” ratings. Cameco reported Q1 net earnings of C$131 million earlier in May.
Firefly Aerospace Stock (NASDAQ: FLY) News Today, Dec. 19, 2025: Analyst Coverage, Lawsuit Deadline, and What Investors Are Watching
Previous Story

Firefly Aerospace Stock (NASDAQ: FLY) News Today, Dec. 19, 2025: Analyst Coverage, Lawsuit Deadline, and What Investors Are Watching

Hawaiian Electric Industries (HE) Stock Today: Settlement Timeline, S&P 600 Inclusion, and What Analysts Expect Next (Dec. 19, 2025)
Next Story

Hawaiian Electric Industries (HE) Stock Today: Settlement Timeline, S&P 600 Inclusion, and What Analysts Expect Next (Dec. 19, 2025)

Go toTop